Refractory malignant glaucoma after secondary IOL implantation in an eye with 17-year-old vitrectomy: A case report

一例17年前行玻璃体切除术后行二次人工晶状体植入术后难治性恶性青光眼:病例报告

阅读:1

Abstract

RATIONALE: Malignant glaucoma (MG) results from aqueous misdirection and entrapment in the vitreous cavity. This process drives anterior displacement of the lens-iris diaphragm, causing uniform shallowing of the central and peripheral anterior chamber, typically with elevated intraocular pressure (IOP). Clear lens extraction with anterior vitrectomy remains the definitive intervention. PATIENT CONCERNS: We report a rare case of MG following combined pars plana vitrectomy (PPV) and intraocular lens (IOL) implantation and detail its management. A 49-year-old Chinese male presented with a history of ocular trauma in the left eye, which was treated 17 years ago by PPV with lensectomy. After secondary IOL implantation with pupilloplasty was successfully performed, the patient experienced recurrent episodes of shallow anterior chamber and elevated IOP (peaking at 44 mm Hg), which could not be resolved by maximal medical therapy, suture-leakage assisted incision, or laser peripheral iridotomy. DIAGNOSES: The condition was considered postoperative MG. INTERVENTIONS: The patient underwent a second surgery, which was trabeculectomy combined with partial irido-zonulo-hyaloid-vitrectomy. OUTCOMES: Subsequent follow-up demonstrated stable anterior chamber depth and normalized IOP. LESSONS: To resolve MG, the fundamental objective must be restoring pressure equilibrium across the ciliary body-zonules-lens-hyaloid-anterior vitreous complex. Achieving this requires reconstructing the complex's structural integrity and normalizing its regulatory function in aqueous humor circulation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。